Serum fibroblast growth factor-23 levels in chronic haemodialysis patients

被引：0
|
作者：
Salwa Ibrahim
Laila Rashed
机构：
[1] Cairo University,Department of Medicine
[2] Cairo University,Department of Biochemistry
来源：
International Urology and Nephrology | 2009年 / 41卷
关键词：
Fibroblast growth factor 23; Hemodialysis; Hyperparathyroidism; Hyperphosphataemia; End-stage renal disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：163 / 169
页数：6
相关论文
共 50 条
  • [21] Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease
    Ekaterini Siomou
    Anna Challa
    Nikoleta Printza
    Vasileios Giapros
    Fotini Petropoulou
    Andromachi Mitsioni
    Fotios Papachristou
    Constantinos J. Stefanidis
    Pediatric Nephrology, 2011, 26 : 1105 - 1114
  • [22] FIBROBLAST GROWTH FACTOR-23 AND HYPOPHOSPHATEMIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
    Elsammak, Mohamed Y.
    Attia, Adel
    Suleman, Moosa
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2012, 31 (01) : 12 - 18
  • [23] Regulation of fibroblast growth factor-23 in chronic kidney disease
    Westerberg, Per-Anton
    Linde, Torbjoern
    Wikstroem, Bjoern
    Ljunggren, Oesten
    Stridsberg, Mats
    Larsson, Tobias E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) : 3202 - 3207
  • [24] Fibroblast growth factor-23 and Klotho in chronic kidney disease
    Vervloet, Marc G.
    Larsson, Tobias E.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2011, 1 (04) : 130 - 135
  • [25] Serum vitamin D receptor and fibroblast growth factor-23 levels in postmenopausal primary knee osteoarthritis patients
    Tekeli, Feyza Yagmur
    Tekeli, Seckin Ozgur
    Kose, Ozkan
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2022, 47 (06): : 788 - 794
  • [26] Fibroblast growth factor-23 as a possible cause of left ventricular hypertrophy and pulmonary hypertension in haemodialysis patients
    El-Adawy, Noussa Mahmoud
    Helmy, Amal Kamal
    Ismail, Tamer Taha
    Tawfik, Abd El Rahman Sayed
    Keryakos, Hesham Kamal Habeeb
    Abu Ela, Mostafa Ahmed El Sayed
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0H) : H2 - H2
  • [27] FIBROBLAST GROWTH FACTOR-23 LEVELS IN CHRONIC RENAL FAILURE PATIENTS ON DIFFERENT DIALYSIS TREATMENTS AND IN PATIENTS WITH RENAL TRANSPLANTATION
    Ozdem, S.
    Ersoy, F.
    Yilmaz, V. T.
    Donmez, L.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S567 - S567
  • [28] Fibroblast Growth Factor-23 Levels Are Associated with Vascular Calcifications in Peritoneal Dialysis Patients
    Asicioglu, Ebru
    Kahveci, Arzu
    Arikan, Hakki
    Koc, Mehmet
    Tuglular, Serhan
    Ozener, Cetin Ishak
    NEPHRON CLINICAL PRACTICE, 2013, 124 (1-2): : 89 - 93
  • [29] Impact of etelcalcetide on fibroblast growth factor-23 and calciprotein particles in patients with secondary hyperparathyroidism undergoing haemodialysis
    Hashimoto, Yusaku
    Kato, Sawako
    Kuro-o, Makoto
    Miura, Yutaka
    Itano, Yuya
    Ando, Masahiko
    Kuwatsuka, Yachiyo
    Maruyama, Shoichi
    NEPHROLOGY, 2022, 27 (09) : 763 - 770
  • [30] Impact of sevelamer hydrochloride on fibroblast growth factor-23 levels in patients undergoing hemodialysis
    Ahmed, Fatma Abdelrahman
    Khalil, Amr
    Elsaid, Tamer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2548 - I2548
12345